Sit Investment Associates Inc. Sells 2,025 Shares of Steris Plc (STE)
Sit Investment Associates Inc. lowered its position in shares of Steris Plc (NYSE:STE) by 5.8% during the second quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 32,975 shares of the medical equipment provider’s stock after selling 2,025 shares during the period. Sit Investment Associates Inc.’s holdings in Steris Plc were worth $2,687,000 at the end of the most recent quarter.
Other large investors have also modified their holdings of the company. Dimensional Fund Advisors LP raised its position in shares of Steris Plc by 3.8% in the fourth quarter. Dimensional Fund Advisors LP now owns 450,870 shares of the medical equipment provider’s stock valued at $30,386,000 after buying an additional 16,595 shares during the last quarter. Thrivent Financial for Lutherans raised its position in shares of Steris Plc by 7.2% in the fourth quarter. Thrivent Financial for Lutherans now owns 14,860 shares of the medical equipment provider’s stock valued at $1,001,000 after buying an additional 1,000 shares during the last quarter. RMB Capital Management LLC purchased a new position in shares of Steris Plc during the fourth quarter valued at approximately $14,929,000. Teachers Advisors LLC raised its position in shares of Steris Plc by 9.1% in the fourth quarter. Teachers Advisors LLC now owns 200,351 shares of the medical equipment provider’s stock valued at $13,502,000 after buying an additional 16,717 shares during the last quarter. Finally, CENTRAL TRUST Co increased its stake in shares of Steris Plc by 1.3% in the first quarter. CENTRAL TRUST Co now owns 3,670 shares of the medical equipment provider’s stock valued at $255,000 after buying an additional 47 shares during the period. Hedge funds and other institutional investors own 91.80% of the company’s stock.
Shares of Steris Plc (NYSE:STE) opened at 86.70 on Wednesday. Steris Plc has a 1-year low of $63.80 and a 1-year high of $87.49. The stock has a 50 day moving average price of $82.15 and a 200-day moving average price of $74.62. The company has a market cap of $7.37 billion, a P/E ratio of 67.73 and a beta of 1.33.
Steris Plc (NYSE:STE) last posted its earnings results on Tuesday, August 8th. The medical equipment provider reported $0.85 earnings per share (EPS) for the quarter, topping the Thomson Reuters’ consensus estimate of $0.80 by $0.05. The business had revenue of $608 million for the quarter, compared to analysts’ expectations of $597.66 million. Steris Plc had a net margin of 4.20% and a return on equity of 11.12%. The business’s revenue for the quarter was down 4.8% compared to the same quarter last year. During the same period in the prior year, the company posted $0.79 EPS. Analysts predict that Steris Plc will post $4.04 earnings per share for the current fiscal year.
ILLEGAL ACTIVITY NOTICE: This story was first reported by The Cerbat Gem and is the sole property of of The Cerbat Gem. If you are reading this story on another site, it was copied illegally and reposted in violation of United States and international copyright & trademark law. The original version of this story can be viewed at https://www.thecerbatgem.com/2017/08/09/steris-plc-ste-shares-sold-by-sit-investment-associates-inc-updated-updated.html.
Several analysts recently issued reports on STE shares. Zacks Investment Research raised Steris Plc from a “sell” rating to a “hold” rating in a report on Friday, June 23rd. KeyCorp raised Steris Plc from a “sector weight” rating to an “overweight” rating and set a $89.00 price target on the stock in a report on Wednesday, May 3rd. BidaskClub downgraded Steris Plc from a “strong-buy” rating to a “buy” rating in a report on Monday, July 31st. Finally, Wellington Shields downgraded Steris Plc from a “gradually accumulate” rating to a “hold” rating in a research note on Monday, June 5th. Two analysts have rated the stock with a hold rating and four have assigned a buy rating to the company. Steris Plc presently has an average rating of “Buy” and a consensus price target of $84.00.
In other news, VP Sudhir K. Pahwa sold 800 shares of the stock in a transaction on Thursday, May 25th. The shares were sold at an average price of $77.28, for a total value of $61,824.00. The sale was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, Director Michael B. Wood sold 4,000 shares of the stock in a transaction on Monday, July 3rd. The stock was sold at an average price of $81.50, for a total transaction of $326,000.00. Following the completion of the transaction, the director now directly owns 26,131 shares in the company, valued at approximately $2,129,676.50. The disclosure for this sale can be found here. Insiders sold a total of 30,340 shares of company stock worth $2,432,704 in the last three months. Insiders own 2.55% of the company’s stock.
About Steris Plc
STERIS plc provides infection prevention and other procedural products and services. The Company operates through four segments: Healthcare Products, which offers infection prevention and procedural solutions for healthcare providers, including capital equipment and related maintenance, and installation services, as well as consumables; Healthcare Specialty Services, which provides a range of specialty services for healthcare providers, including hospital sterilization services, instrument and scope repairs, and linen management; Life Sciences, which offers capital equipment and consumable products, and equipment maintenance and specialty services for pharmaceutical manufacturers and research facilities, and Applied Sterilization Technologies, which offers contract sterilization and laboratory services for medical device and pharmaceutical customers and others.
Receive News & Stock Ratings for Steris Plc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Steris Plc and related stocks with our FREE daily email newsletter.